Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
19 Sep 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/diagnostic-center/curateq-biologics-completes-phase-3-clinical-study-for-denosumab-biosimilar-17842
27 Aug 2025
// BUSINESS STD
https://www.business-standard.com/industry/news/aurobindo-pharma-subsidiary-uk-approval-breast-cancer-drug-dazublys-125082601330_1.html
30 Jun 2025
// EMA
https://www.ema.europa.eu/en/documents/overview/dazublys-epar-medicine-overview_en.pdf
14 May 2025
// THEHINDU
https://www.thehindu.com/business/aurobindo-pharma-arms-biosimilar-gets-marketing-nod-from-uks-mhra/article69572375.ece
28 Apr 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/drug-approval/curateq-biologics-receives-positive-opinion-for-biosimilar-dazublys-from-ema-17080
09 Apr 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/curateq-biologics-completes-phase-1-pharmacokinetics-study-of-biosimilar-denosumab-17000
ABOUT THIS PAGE